Navigation Links
Preliminary Financial Results, Quarterly Reports and Upcoming Conference Schedules - Research Report on Avanir, BioScrip, Chemed, Foundation Medicine, and Antares
Date:11/11/2013

r basic and diluted share, compared with a net loss of $0.03 per basic and diluted share, in Q3 2012. "Last month's approval of OTREXUP represented a strategic milestone in the transformation of Antares from a royalty based business to a specialty pharmaceutical company generating potential product revenue from proprietary in-house development programs," said Paul K. Wotton, Ph.D., President and CEO of Antares. "We believe that OTREXUP could become an important part of the treatment continuum for RA patients and look forward to launching the product early in 2014." The Full Research Report on Antares Pharma, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:

[http://www.analystscorner.com/r/full_research_report/2353_ATRS]

----

EDITOR NOTES:

  1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
  2. Information in this release is fact checked and produced on a best efforts basis and reviewed by Ananya Ghosh, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
  3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
  4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco@EquityNewsNetwork.com.
  5. For any urgent concerns or inquiries, please contact us at compliance@EquityNewsNetwork.com.
  6. Are you a public company? Would you like to see similar coverage on
    '/>"/>

SOURCE Analysts' Corner
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Preliminary Phase 2 Data of Ocera Therapeutics OCR-002 for the Treatment of Liver Cirrhosis and Upper GI Bleeding Show Potent Ammonia Reduction
2. OncoSec Presents Preliminary Safety Data for Phase II Melanoma Study at Second European Post-Chicago Melanoma Meeting 2012
3. Pro-Dex Provides Insight Into Fiscal 2013 Operating Plan And Preliminary Results For Fiscal 2012
4. Simcere Pharmaceutical Group Reports Preliminary Unaudited Second Quarter 2012 Results
5. Lexicon Pharmaceuticals Reports Preliminary Results From Two Phase 1 Studies
6. CareFusion To Report Preliminary Fiscal 2013 First Quarter Results On Nov. 8
7. Cardinal Health Announces Preliminary Shareholder Voting Results at 2012 Annual Meeting
8. CareFusion Reports Preliminary First Quarter Fiscal 2013 Results
9. OncoSec Medical Reports Positive Preliminary Efficacy Results from Phase II Study of ImmunoPulse in Metastatic Melanoma Patients
10. Simcere Pharmaceutical Group Reports Preliminary Unaudited Third Quarter 2012 Results
11. Avanir Pharmaceuticals Pre-Announces Preliminary Fiscal 2012 Fourth Quarter Results And Provides Clinical Study Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... , Sept. 19, 2014  BioSpecifics Technologies Corp. (NASDAQ: ... class collagenase-based products marketed as XIAFLEX ® in the ... that BioSpecifics, President, Tom Wegman , will present a ... in the Biotech Industry Conference. The presentation ... p.m. EDT at the Millennium Broadway Hotel in ...
(Date:9/19/2014)... , Sept. 19, 2014  Over 200 runners ... Future to Benefit the Radiation Oncology Institute (ROI), hosted ... at Golden Gate Park in San Francisco.  ... Moore , CEO of Radiation Business Solutions, "but ... have raised over $70,000 for the ROI this year. ...
(Date:9/19/2014)... Mass. , Sept. 19, 2014   Personal ... advanced cancer genome analysis and testing services, and ... and developing highly selective kinase inhibitors for genomically ... study of malignant mixed Mullerian tumors (MMMT), an ... system, also known as carcinosarcoma. The new ...
Breaking Medicine Technology:BioSpecifics Technologies Corp. to Present at the 21st Annual BioCentury NewsMakers in the Biotech Industry Conference 2Fifth Annual 5K Run for the Future to Benefit the Radiation Oncology Institute Breaks Attendance, Donation Records 2Fifth Annual 5K Run for the Future to Benefit the Radiation Oncology Institute Breaks Attendance, Donation Records 3First Discovery Of Actionable Genetic Alterations In A Deadly Cancer Reported By Personal Genome Diagnostics And Blueprint Medicines 2First Discovery Of Actionable Genetic Alterations In A Deadly Cancer Reported By Personal Genome Diagnostics And Blueprint Medicines 3First Discovery Of Actionable Genetic Alterations In A Deadly Cancer Reported By Personal Genome Diagnostics And Blueprint Medicines 4
(Date:9/21/2014)... Burnaby Physiotherapists at Absolute PhysioCare & Sports ... to help them with preventative care. This is part ... will help clients understand their problem in a better ... in the healing process. With higher knowledge of their ... to facilitate the therapy that is initiated by the ...
(Date:9/21/2014)... 21, 2014 "I wanted to be ... to consume sugary, foul-tasting energy drinks," said an inventor ... just want to drink plain, old coffee. That is ... , He developed ENERG CHEWING GUM to provide a ... loss. The formula contains nutritious vitamins, minerals and antioxidants. ...
(Date:9/21/2014)... New York, New York (PRWEB) September 21, 2014 ... http://www.risperdallawsuitcenter.com/ ) continue to move forward in Pennsylvania’s ... reports. According to court documents, the proceeding’s next ... 2014. (Risperdal Litigation, case number 100300296) , “Our ... have filed Risperdal lawsuits in this litigation. We ...
(Date:9/21/2014)... Originally approved by the Food ... (fluticasone propionate) is a synthetic ICS therapy with ... maintenance treatment of asthma prophylactically in children and ... Diskus and HFA, which received the FDA approval ... fluticasone propionate, can bind to glucocorticoid receptors with ...
(Date:9/21/2014)... (PRWEB) September 21, 2014 An experienced ... released its newest hosting ranking list and announced that ... best VPS hosting suppliers. , There has been ... new demand has resulted in an increase in the ... of different services at very affordable prices. VPS (Virtual ...
Breaking Medicine News(10 mins):Health News:Burnaby Physiotherapists Now Provide Educational Information for Preventative Care 2Health News:Risperdal Lawsuits Move Forward in Pennsylvania Litigation, As Court Schedules October Meeting, Bernstein Liebhard LLP Reports 2Health News:Risperdal Lawsuits Move Forward in Pennsylvania Litigation, As Court Schedules October Meeting, Bernstein Liebhard LLP Reports 3Health News:Risperdal Lawsuits Move Forward in Pennsylvania Litigation, As Court Schedules October Meeting, Bernstein Liebhard LLP Reports 4Health News:Flovent Asthma Market Sales & SWOT Analysis and Forecasts to 2023 in New Report Available at LifeScienceIndustryResearch.com 2Health News:Flovent Asthma Market Sales & SWOT Analysis and Forecasts to 2023 in New Report Available at LifeScienceIndustryResearch.com 3Health News:Flovent Asthma Market Sales & SWOT Analysis and Forecasts to 2023 in New Report Available at LifeScienceIndustryResearch.com 4Health News:Top10BestSEOHosting.com: FatCow, GoDaddy And Bluehost Are The Best VPS Hosting Suppliers 2
... Menveo not available in US yet, British researchers note , , ... meningitis vaccine appears to offer protection for babies against several ... and Canadian researchers report. , The new vaccine, which is ... four strains of meningococcal disease in all age groups, according ...
... a stage, then proteins would rank among the lead ... These large biological molecules hold many starring roles, and ... genes. They are production powerhouses, regulating the basic processes ... that produce or use energy. Others regulate genes. , ...
... enjoy things less. Such satiation causes our favorites to lose ... pushes us to escalate our spending on novelty. Life has ... better and better experiences just to stay happy. However, new ... Research finds that paying attention to details can help us ...
... and Queens Groups Will Work to Prevent Sudden Cardiac,Arrest, ... 8 The Sudden Cardiac Arrest,Association (SCAA) announced today ... it builds a network of local organizations to help ... The Queens chapter is led by Lorraine Monaghan, ...
... Work to Prevent Sudden Cardiac Arrest, Through Public ... Sudden Cardiac Arrest,Association (SCAA) announced today that it has ... of local organizations to help carry out,its mission of ... chapter is led by Connie Snell of Austin who ...
... WASHINGTON, Jan. 8 The Department of Labor,s,Occupational ... comment period for the review of its methylene ... was originally announced in,the July 10, 2007, Federal ... issued the Standard in 1997 to protect employees ...
Cached Medicine News:Health News:New Meningitis Vaccine Works in Infants 2Health News:New Meningitis Vaccine Works in Infants 3Health News:Protein power: Researchers trigger insulin production in diabetic mice 2Health News:Protein power: Researchers trigger insulin production in diabetic mice 3Health News:Trying to stay on a strict diet? Focus on the details 2Health News:Sudden Cardiac Arrest Association Launches Long Island and Queens Chapters 2Health News:Sudden Cardiac Arrest Association Launches Long Island and Queens Chapters 3Health News:Sudden Cardiac Arrest Association Launches Austin and Lubbock Chapters 2Health News:Sudden Cardiac Arrest Association Launches Austin and Lubbock Chapters 3Health News:OSHA Extends Comment Period for Lookback Review of Methylene Chloride Standard 2
... The new face-lifted Leica RM2125 microtome ... Leica RM2125 and Leica RM2125 RT. All ... cover to avoid debris entering the precision ... comes with a two-step trimming function and ...
... scale heavy-duty sectioning system is the standard microtome ... a real working animal. ,Large specimens up to ... as bone or teeth and whole organs (brain, ... of accessories, specially designed for paraffin and resin ...
... Designed for biomedical and industrial applications, the ... a variety of applications in all laboratories ... to be sectioned. Its sturdy construction lends ... The safety features of the system, such ...
... The Leica SM2000 R sliding ... designed to section paraffin-embedded samples in ... can also be used for some ... is available fully equipped to meet ...
Medicine Products: